US Stock MarketDetailed Quotes

ELDN Eledon Pharmaceuticals

Watchlist
  • 2.290
  • -0.100-4.18%
Close May 1 16:00 ET
56.82MMarket Cap-1396P/E (TTM)

Eledon Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-39.06%-39.53M
3.68%-9.13M
-168.02%-12.25M
-32.23%-8.22M
-21.68%-9.92M
1.69%-28.42M
-2.95%-9.48M
35.56%-4.57M
16.51%-6.22M
-57.88%-8.16M
Net income from continuing operations
54.16%-40.33M
83.51%-9.63M
1.17%-10.35M
-3.59%-9.58M
-9.21%-10.77M
-154.93%-87.97M
-563.00%-58.38M
-6.66%-10.47M
-25.23%-9.25M
-16.06%-9.86M
Depreciation and amortization
0.27%374K
1.08%94K
1.08%94K
0.00%94K
-1.08%92K
91.28%373K
52.46%93K
111.36%93K
113.64%94K
102.17%93K
Change In working capital
-307.64%-4.92M
47.75%-685K
-189.67%-3.25M
-157.17%-359K
-9.46%-625K
1,657.89%2.37M
32.32%-1.31M
173.77%3.62M
140.46%628K
-128.35%-571K
-Change in prepaid assets
-398.78%-1.95M
-11.90%-1.6M
-243.38%-1.15M
-11.36%320K
-48.86%471K
131.22%654K
30.00%-1.43M
40,100.00%800K
240.57%361K
679.25%921K
-Change in payables and accrued expense
-224.94%-2.6M
380.48%1.01M
-168.86%-2.01M
-262.95%-585K
27.34%-1.02M
-2.89%2.08M
28.83%210K
112.47%2.91M
122.28%359K
-163.11%-1.4M
-Change in other current liabilities
1.09%-363K
-3.23%-96K
-4.40%-95K
-2.17%-94K
14.29%-78K
-83.50%-367K
-55.00%-93K
-97.83%-91K
-95.74%-92K
-93.62%-91K
Cash from discontinued investing activities
Operating cash flow
-39.06%-39.53M
3.68%-9.13M
-168.02%-12.25M
-32.23%-8.22M
-21.68%-9.92M
1.69%-28.42M
-2.95%-9.48M
35.56%-4.57M
16.51%-6.22M
-57.88%-8.16M
Investing cash flow
Cash flow from continuing investing activities
-45.29M
10.08M
-25.03M
0
0
0
Net investment purchase and sale
---45.29M
--10.08M
---25.03M
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
---45.29M
--10.08M
---25.03M
----
----
--0
--0
--0
----
----
Financing cash flow
Cash flow from continuing financing activities
33.02M
0
0
0
0
0
Net common stock issuance
--33.02M
--0
--0
----
----
--0
--0
--0
----
----
Cash from discontinued financing activities
Financing cash flow
--33.02M
--0
--0
----
----
--0
--0
--0
----
----
Net cash flow
Beginning cash position
-33.51%56.41M
-94.43%3.67M
-41.89%40.95M
-39.38%46.49M
-33.51%56.41M
-25.71%84.83M
-29.94%65.89M
-30.33%70.46M
-29.38%76.68M
-25.71%84.83M
Current changes in cash
-82.23%-51.8M
109.97%945K
-715.58%-37.28M
10.92%-5.54M
-21.68%-9.92M
3.19%-28.42M
-2.95%-9.48M
35.55%-4.57M
16.51%-6.22M
-45.23%-8.16M
End cash Position
-91.82%4.61M
-91.82%4.61M
-94.43%3.67M
-41.89%40.95M
-39.38%46.49M
-33.51%56.41M
-33.51%56.41M
-29.94%65.89M
-30.33%70.46M
-29.38%76.68M
Free cash flow
-39.06%-39.53M
3.68%-9.13M
-168.02%-12.25M
-32.23%-8.22M
-21.68%-9.92M
1.69%-28.42M
-2.95%-9.48M
35.56%-4.57M
16.51%-6.22M
-57.88%-8.16M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -39.06%-39.53M3.68%-9.13M-168.02%-12.25M-32.23%-8.22M-21.68%-9.92M1.69%-28.42M-2.95%-9.48M35.56%-4.57M16.51%-6.22M-57.88%-8.16M
Net income from continuing operations 54.16%-40.33M83.51%-9.63M1.17%-10.35M-3.59%-9.58M-9.21%-10.77M-154.93%-87.97M-563.00%-58.38M-6.66%-10.47M-25.23%-9.25M-16.06%-9.86M
Depreciation and amortization 0.27%374K1.08%94K1.08%94K0.00%94K-1.08%92K91.28%373K52.46%93K111.36%93K113.64%94K102.17%93K
Change In working capital -307.64%-4.92M47.75%-685K-189.67%-3.25M-157.17%-359K-9.46%-625K1,657.89%2.37M32.32%-1.31M173.77%3.62M140.46%628K-128.35%-571K
-Change in prepaid assets -398.78%-1.95M-11.90%-1.6M-243.38%-1.15M-11.36%320K-48.86%471K131.22%654K30.00%-1.43M40,100.00%800K240.57%361K679.25%921K
-Change in payables and accrued expense -224.94%-2.6M380.48%1.01M-168.86%-2.01M-262.95%-585K27.34%-1.02M-2.89%2.08M28.83%210K112.47%2.91M122.28%359K-163.11%-1.4M
-Change in other current liabilities 1.09%-363K-3.23%-96K-4.40%-95K-2.17%-94K14.29%-78K-83.50%-367K-55.00%-93K-97.83%-91K-95.74%-92K-93.62%-91K
Cash from discontinued investing activities
Operating cash flow -39.06%-39.53M3.68%-9.13M-168.02%-12.25M-32.23%-8.22M-21.68%-9.92M1.69%-28.42M-2.95%-9.48M35.56%-4.57M16.51%-6.22M-57.88%-8.16M
Investing cash flow
Cash flow from continuing investing activities -45.29M10.08M-25.03M000
Net investment purchase and sale ---45.29M--10.08M---25.03M----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow ---45.29M--10.08M---25.03M----------0--0--0--------
Financing cash flow
Cash flow from continuing financing activities 33.02M00000
Net common stock issuance --33.02M--0--0----------0--0--0--------
Cash from discontinued financing activities
Financing cash flow --33.02M--0--0----------0--0--0--------
Net cash flow
Beginning cash position -33.51%56.41M-94.43%3.67M-41.89%40.95M-39.38%46.49M-33.51%56.41M-25.71%84.83M-29.94%65.89M-30.33%70.46M-29.38%76.68M-25.71%84.83M
Current changes in cash -82.23%-51.8M109.97%945K-715.58%-37.28M10.92%-5.54M-21.68%-9.92M3.19%-28.42M-2.95%-9.48M35.55%-4.57M16.51%-6.22M-45.23%-8.16M
End cash Position -91.82%4.61M-91.82%4.61M-94.43%3.67M-41.89%40.95M-39.38%46.49M-33.51%56.41M-33.51%56.41M-29.94%65.89M-30.33%70.46M-29.38%76.68M
Free cash flow -39.06%-39.53M3.68%-9.13M-168.02%-12.25M-32.23%-8.22M-21.68%-9.92M1.69%-28.42M-2.95%-9.48M35.56%-4.57M16.51%-6.22M-57.88%-8.16M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg